Financial Year |
March 31 2023 |
Monetary Funds |
664,828,034.52 |
Held-for-trading Financial Assets |
19,998,000.00 |
Notes Receivable |
2,568,682.72 |
Accounts Receivable |
658,305,565.32 |
Advances to Suppliers |
104,506,731.13 |
Other Receivables |
55,183,100.34 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
658,180,321.38 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,309,928.84 |
Total Current Assets |
2,196,729,463.78 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
484,950,842.48 |
Investment Properties |
16,117,837.02 |
Fixed Assetes |
2,752,211,679.73 |
Under-construction Projects |
149,203,517.97 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
973,399,604.32 |
Oil and Gas Assets |
-- |
Intangible Assets |
767,890,389.39 |
R&D expenses |
-- |
Goodwill |
1,190,018,227.88 |
Long-Term Deferred and Prepaid Expenses |
19,832,134.37 |
Deferred Income Tax Assets |
36,827,704.59 |
Other Non-Current Assets |
55,803,130.39 |
Sub-Total of Non-Current Assets |
7,258,337,208.44 |
Total Assets |
9,455,066,672.22 |
Short-Term Loans |
818,762,771.93 |
Trading Financial liabilities |
8,983,464.94 |
Notes Payable |
-- |
Accounts Payable |
835,722,833.20 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
161,819,359.33 |
Taxes Payable |
69,455,985.05 |
Interest Payable |
-- |
Dividend Payable |
1,797,487.97 |
Other payables |
727,486,254.26 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,461,985,652.74 |
Other Current Liabilities |
23,155,182.33 |
Sub-Total of Current Liabilities |
4,316,099,622.58 |
Long-term Loans |
1,506,850,000.00 |
Bonds Payable |
677,722,450.30 |
Long-Term Accounts Payable |
71,313,700.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
31,056,393.66 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,482,633,776.85 |
Total Liabilities |
6,798,733,399.43 |
Paid-In Capital(Or Share Stock) |
866,583,098.00 |
Capital Surplus |
631,639,415.13 |
Surplus Reserve |
56,260,420.65 |
LESS:Treasury Stock |
82,910,770.00 |
Undistributed Profits |
1,436,634,174.76 |
Minority Stockholder's Interest |
148,440,391.40 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,507,892,881.39 |
Owner's Equity(Stockholder's Equity) |
2,656,333,272.79 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
9,455,066,672.22 |